HOME
ABOUT US
STRATEGY
TEAM
PORTFOLIO
NEWSROOM
CONTACT
More
4BIO Capital leads oversubscribed $28.4 million Series A financing of March Biosciences
4BIO Capital jointly leads $25 million Series A financing of ViaNautis Bio
4BIO Capital Participates in $130M Funding of New Gene and Cell Manufacturing Specialist Ascend
4BIO Capital Portfolio Company Code Biotherapeutics Closes an Oversubscribed $75 Million Series A
4BIO Capital co-leads $30 million (¥3.86 Billion) oversubscribed Series B financing in LUCA Science
4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics